Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans

Leukemia(2021)10.1038/s41375-021-01344-9Source: DataRank Database

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans is a research paper published in Leukemia (2021). On theSindex it has a DataRank of 0.726. It has been cited 22 times, with 12 citing works in its 1-hop citation network.

N/A

0.726DataRank · unranked

Scored on demand from live citation data

Open Access22 citations · 12 citing works in its network

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (17 grants)Impact (FWCI 1.75)OA: hybridTopics (115)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 65%Citation Network 35%

Base Score Contribution

0.470

From this paper's citation signal

Citation Network Contribution

0.255

From 9 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 12 citers.

The clonal evolution and natural history of MBL
Blood20222 citations10 referencesContributes 0.110
Linfocitosis monoclonal de células B en familiares de pacientes colombianos con síndromes linfoproliferativos crónicos B
Biomédica20231 citations22 referencesContributes 0.032
Influence of Racial and Ethnic Identity on Overall Survival in Patients with Chronic Lymphocytic Leukemia
Research Square20222 citations35 referencesContributes 0.031
Role of Polygenic Risk Score in Cancer Precision Medicine of Non-European Populations: A Systematic Review
Current Oncology20229 citations75 referencesContributes 0.031
Lymphocyte count and risk of chronic lymphocytic leukemia
JNCI Journal of the National Cancer Institute20251 citations28 referencesContributes 0.025

Authors (22)

J. Brice Weinberg ORCID,Sameer A. Parikh ORCID,Esteban Braggio ORCID,Sara J. Achenbach,Dennis P. Robinson ORCID

Live enrichment

PubMed:34285341 PMC:PMC8727288 OpenAlex:https://openalex.org/W3185838112

NCI NIH HHS

Grant: P30 CA015083

NCI NIH HHS

Grant: R01 CA197120

NCI NIH HHS

Grant: R01 CA235026

NCI NIH HHS

Grant: P30 CA014236

NCI NIH HHS

Grant: R01 CA200703

NCI NIH HHS

Grant: R01 CA254951

NCI NIH HHS

Grant: P50 CA097274

NIA NIH HHS

Grant: R01 AG058266

NCI NIH HHS

Grant: R25 CA092049

NCI NIH HHS

Grant: P01 CA081534

National Institutes of Health

Grant: 5R25CA092049-14

Mayo Cancer Genetic Epidemiology Training Program

National Institutes of Health

Grant: 1R01CA197120-01

Predicting clinical outcome in individuals with small CLL B cell clones

National Institutes of Health

Grant: 5P01CA081534-09

Immune Tolerance of CLL Antigens

National Institutes of Health

Grant: 5R01CA200703-05

Genetic Epidemiology of non-Hodgkin Lymphoma

National Institutes of Health

Grant: 5R01CA235026-05

Integration of germline and tumor genomes in CLL

National Institutes of Health

Grant: 2P50CA097274-06

Biostatistics and Bioinformatics

National Institutes of Health

Grant: 5R01AG058266-04

Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)

FWCI

1.75

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://www.nature.com/articles/s41375-021-01344-9.pdf

publisherhttps://www.nature.com/articles/s41375-021-01344-9.pdf

publisherhttps://www.nature.com/articles/s41375-021-01344-9

journalhttps://doi.org/10.1038/s41375-021-01344-9

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34285341

Fields of Study

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentAcute Lymphoblastic Leukemia research0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AdultAgedAged, 80 and overB-LymphocytesBlack or African AmericanClone CellsFemaleFollow-Up StudiesHumansImmunoglobulinsLymphocytosisMaleMiddle AgedPrognosisRisk FactorsBiomarkers, TumorUnited StatesLeukemia, Lymphocytic, Chronic, B-CellCase-Control StudiesImmunophenotypingWhite People

Keywords

LymphocytosisChronic lymphocytic leukemiaLeukemiaMedicineMonoclonalImmunologyInternal medicineHematologyMonoclonal antibodyOncologyAntibodyMaleLymphomaHealth Disparities (rcdc)Risk FactorsCardiovascular Medicine and Haematology1103 Clinical Sciences (for)80 and over80 and over (mesh)Minority HealthLymphatic Research (rcdc)Chronic32 Biomedical and Clinical Sciences (for-2020)Male (mesh)White People (mesh)CancerCancer (rcdc)Aged, 80 and overClone Cells (mesh)Humans (mesh)B-LymphocytesTumorLymphoma (rcdc)Follow-Up Studies (mesh)3201 Cardiovascular medicine and haematology (for-2020)1112 Oncology and Carcinogenesis (for)Middle AgedPrognosisImmunophenotyping (mesh)LymphocyticHealth DisparitiesMinority Health (rcdc)FemaleTumor (mesh)United States (mesh)Immunology (science-metrix)AdultLymphatic ResearchClinical SciencesOncology and CarcinogenesisBlack or African American (mesh)610ImmunoglobulinsWhite PeopleCase-Control Studies (mesh)ArticleImmunophenotypingRare Diseases (rcdc)Rare DiseasesRisk Factors (mesh)Middle Aged (mesh)GeneticsBiomarkers, Tumor3211 Oncology and carcinogenesis (for-2020)Humans3202 Clinical Sciences (for-2020)AgedHematology (rcdc)Biomedical and Clinical SciencesGenetics (rcdc)Aged (mesh)B-Lymphocytes (mesh)Human GenomeLymphocytosis (mesh)B-CellPrognosis (mesh)Human Genome (rcdc)Leukemia, Lymphocytic, Chronic, B-CellUnited StatesClone CellsBlack or African AmericanFemale (mesh)B-Cell (mesh)Case-Control StudiesImmunoglobulins (mesh)Adult (mesh)BiomarkersFollow-Up Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 10: 10. No inequalitySDG 0: Life in Land

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (22)

Funding (17 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)